Search

everythinglearnresearchcommunity

for

Search:↓

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Some bacteria use arsenic compounds as antibiotics, and others have evolved resistance; a particular arsenic-based compound shows potential as a new antimalarial treatment.

Enzymes can release hydrocarbons from Botryococcus braunii without harming cells, suggesting potential for continuous extraction.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Analog 23 is a promising compound for prostate cancer treatment.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Bruguiera gymnorhiza leaf extracts show potential for developing anti-inflammatory drugs.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

New progesterone-based compounds can block male hormones.

Centipeda minima and brevilin A protect skin cells from damage and aging.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.